THURSDAY, Nov. 9, 2023 (HealthDay News) — There’s good news for folks who lost some of their sense of taste and smell after a bout of mild COVID: New research shows this side effect largely resolves by three years after infection. Italian researchers looked at post-COVID outcomes for 88 peopleContinue Reading
TUESDAY, Nov. 7, 2023 (HealthDay News) — Many new moms, particularly those on Medicaid, struggle to get health care and social support in the year following their baby’s birth, new research reveals. “Most people think of labor and birth as the most dangerous part of pregnancy, but the highest riskContinue Reading
FRIDAY, Nov. 3, 2023 (HealthDay News) — It’s time to turn your clocks back this Sunday, and a leading group of sleep experts want that return to standard time to be permanent. The American Academy of Sleep Medicine (AASM) has issued a new position statement recommending the elimination of seasonalContinue Reading
FRIDAY, Nov. 3, 2023 (HealthDay News) — As many as 1 in 3 people who fall ill with COVID-19 will develop long COVID, with symptoms that can persist for months or years, a new study estimates. Nearly half of participants (47%) in a large-scale U.S. Census Bureau survey said theyContinue Reading
THURSDAY, Nov. 2, 2023 (HealthDay News) — A procedure to treat the irregular heart rhythm condition known as atrial fibrillation (a-fib) works just as well for women as it does for men, new research shows. The technology, called pulsed field ablation (PFA), can be used to restore a regular heartbeat.Continue Reading
TUESDAY, Oct. 31, 2023 (HealthDay News) — The antiviral drug Paxlovid is great at treating COVID-19 infections, but a new study casts doubt on its effectiveness at preventing symptoms associated with long COVID. Nearly 9,600 veterans given Paxlovid had about the same risk of most post-COVID side effects as vetsContinue Reading
MONDAY, Oct. 30, 2023 (HealthDay News) — Americans have been getting COVID treatments such as Paxlovid for free, but that’s about to end. The medications will enter the private market this week, the Associated Press reported. The price for a five-day course of Paxlovid, made by Pfizer, will be $1,390.Continue Reading
THURSDAY, Oct. 26, 2023 (HealthDay News) — More than half of working-age Americans struggle to afford their health care and many forgo care, possibly risking their health, according to a new survey. The Commonwealth Fund survey queried more than 7,800 individuals aged 19 and up between April and July. TheContinue Reading
WEDNESDAY, Oct. 25, 2023 (HealthDay News) – A new, more inclusive definition of infertility has been crafted by the American Society for Reproductive Medicine (ASRM). While the guidance for heterosexual couples with medical reasons for being unable to conceive still exists, the definition has now been expanded to include otherContinue Reading
MONDAY, Oct. 23, 2023 (HealthDay News) — The rate of firearm homicides in the United States decreased in 2022, the first drop seen since a sharp increase emerged early in the pandemic, public health officials reported. In 2022, firearm homicides numbered 5.9 deaths per 100,000 people nationwide, researchers from theContinue Reading